P

Inventor

BELANOFF JOSEPH K

US31 patents
⚠️ This page may combine multiple inventors who share the name “BELANOFF JOSEPH K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CORCEPT THERAPEUTICS INC

22 patents
US7361646B2Apr 22, 2008

Methods for treating gastroesophageal reflux disease

CORCEPT THERAPEUTICS INC29 citations92
US6680310B2Jan 20, 2004

Methods for preventing antipsychotic-induced weight gain

CORCEPT THERAPEUTICS INC45 citations92
US6620802B1Sep 16, 2003

Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist

CORCEPT THERAPEUTICS INC20 citations92
US10238659B2Mar 26, 2019

Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

CORCEPT THERAPEUTICS INC13 citations91
US10881660B2Jan 5, 2021

Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

CORCEPT THERAPEUTICS INC9 citations84
US10842800B2Nov 24, 2020

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

CORCEPT THERAPEUTICS INC5 citations84
US10195214B2Feb 5, 2019

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

CORCEPT THERAPEUTICS INC6 citations84
US6964953B2Nov 15, 2005

Methods for treating stress disorders using glucocorticoid receptor-specific antagonists

CORCEPT THERAPEUTICS INC16 citations84
US11202784B2Dec 21, 2021

Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

CORCEPT THERAPEUTICS INC5 citations81
US7402578B2Jul 22, 2008

Methods for inhibiting cognitive deterioration in adults with down's syndrome

CORCEPT THERAPEUTICS INC8 citations74
US7163934B2Jan 16, 2007

Methods for treating delirium glucocorticoid receptor-specific antagonists

CORCEPT THERAPEUTICS INC7 citations74
US7326697B2Feb 5, 2008

Methods for increasing the therapeutic response to electroconvulsive therapy

CORCEPT THERAPEUTICS INC8 citations73
US11890289B2Feb 6, 2024

Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

CORCEPT THERAPEUTICS INC4 citations72
US11590135B2Feb 28, 2023

Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

CORCEPT THERAPEUTICS INC1 citations71
US11268145B2Mar 8, 2022

Methods for treating Cushing's syndrome

CORCEPT THERAPEUTICS INC3 citations70
US10610534B2Apr 7, 2020

Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

CORCEPT THERAPEUTICS INC2 citations70
US10604807B2Mar 31, 2020

Methods for diagnosing and assessing treatment for Cushing's syndrome

CORCEPT THERAPEUTICS INC3 citations70
US12097210B2Sep 24, 2024

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

CORCEPT THERAPEUTICS INC0 citations62
US11969435B2Apr 30, 2024

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

CORCEPT THERAPEUTICS INC0 citations62
US12226417B2Feb 18, 2025

Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

CORCEPT THERAPEUTICS INC0 citations61
US12109272B2Oct 8, 2024

Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers

CORCEPT THERAPEUTICS INC1 citations59
US7884091B2Feb 8, 2011

Methods for treating delirium using glucocorticoid receptor-specific antagonists

CORCEPT THERAPEUTICS INC0 citations52

BELANOFF JOSEPH K

5 patents

UNIV LELAND STANFORD JUNIOR

3 patents

Corcept Therapeutics

1 patent